Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

How to Get Bylvay (Odevixibat) Covered by Blue Cross Blue Shield in Georgia: ICD-10 Codes, Prior Authorization Forms, and Appeals Timeline

Answer Box: Getting Bylvay Covered in Georgia Bylvay (odevixibat) requires prior authorization from Blue Cross Blue Shield in Georgia and must be dispensed through specialty pharmacy. Key steps: 1) Submit PA request via Availity with ICD-10 code Q44.71 (Alagille syndrome) or cholestasis codes for PFIC, genetic testing results, and

How to Get Revcovi (Elapegademase) Covered by Blue Cross Blue Shield in Virginia: Complete Prior Authorization & Appeals Guide

Quick Answer: Getting Revcovi Covered in Virginia Blue Cross Blue Shield (BCBS) in Virginia requires prior authorization for Revcovi (elapegademase) under medical benefit criteria for ADA-SCID treatment. The fastest path to approval: (1) Confirm your diagnosis with ICD-10 code D81.31 and ADA enzyme levels <1%, (2) Submit PA

Myths vs. Facts: Getting Tavalisse (fostamatinib) Covered by Blue Cross Blue Shield in Washington

Answer Box: Getting Tavalisse Covered by Blue Cross Blue Shield in Washington Myth: Doctor prescription equals automatic coverage. Fact: Tavalisse (fostamatinib) requires prior authorization from all Blue Cross Blue Shield plans in Washington. Success depends on documented failure of first-line therapies (corticosteroids, IVIG, TPO agonists like Promacta), platelet counts <

How to Get Abecma (idecabtagene vicleucel) Covered by Blue Shield of California: Complete Timeline & Appeals Guide 2025

Answer Box: Getting Abecma Covered by Blue Shield California Blue Shield of California requires prior authorization for Abecma (idecabtagene vicleucel) with clinical review taking 24-72 hours for complete submissions. The fastest path: (1) Verify PA requirement via AuthAccel portal, (2) Submit complete clinical package including 4+ prior therapy lines and

Coding That Helps Get Naglazyme (Galsulfase) Approved by Blue Cross Blue Shield in New Jersey: ICD-10, HCPCS J-Code, and NDC Guide

Answer Box: Getting Naglazyme Covered in New Jersey Naglazyme (galsulfase) requires prior authorization from Blue Cross Blue Shield in New Jersey and is covered under medical benefits using HCPCS J1458. Key coding requirements: ICD-10 E76.29 (MPS VI), J1458 (1 unit = 1 mg), weight-based dosing (1 mg/kg weekly), and

How to Get Abecma (idecabtagene vicleucel) Covered by Blue Cross Blue Shield of Michigan: Complete Approval Guide with Forms and Appeal Scripts

Answer Box: Getting Abecma Covered by BCBS Michigan Blue Cross Blue Shield of Michigan requires prior authorization for Abecma (idecabtagene vicleucel) through their medical benefit PA program. Submit requests via the Availity portal under "Medical and Pharmacy Benefit Drug Prior Auth" with complete clinical documentation showing relapsed/refractory

How to Get Venclexta (venetoclax) Covered by Horizon Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Venclexta Covered in New Jersey Horizon Blue Cross Blue Shield of New Jersey requires prior authorization (PA) for Venclexta (venetoclax), covering it as a Tier 5 specialty drug for FDA-approved CLL/SLL and AML indications. To get approved: 1. Verify coverage via Horizon's formulary and

The Complete Checklist to Get Cystadane (betaine anhydrous) Covered by Blue Cross Blue Shield in Illinois: Forms, Appeals, and Approval Strategies

Quick Answer: Getting Cystadane Covered by BCBS Illinois Cystadane (betaine anhydrous) requires prior authorization from Blue Cross Blue Shield of Illinois for all plans. The fastest path to approval: (1) Submit PA through the Carelon Provider Portal with genetic testing confirming homocystinuria (ICD-10 E72.11 or E72.12), elevated homocysteine

Getting Tagrisso (Osimertinib) Covered by Blue Cross Blue Shield in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tagrisso Covered by BCBS North Carolina Fastest Path: Tagrisso (osimertinib) requires prior authorization from Blue Cross Blue Shield of North Carolina for EGFR-mutant NSCLC. Your oncologist must document EGFR mutation testing (exon 19 deletion or L858R), disease staging, and any prior TKI failures. Submit PA via CoverMyMeds

How to Get Therakos CELLEX Photopheresis Covered by Blue Cross Blue Shield in North Carolina: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Therakos CELLEX Covered in North Carolina Blue Cross Blue Shield of North Carolina covers Therakos CELLEX photopheresis for FDA-approved uses like cutaneous T-cell lymphoma (CTCL) and steroid-refractory graft-versus-host disease (GVHD), but requires prior authorization. Your doctor submits a PA request through the BCBS NC provider portal with